HOME >> MEDICINE >> NEWS
Novel 'metal-chelation' therapy may be helpful in patients with Alzheimer disease

CHICAGO A preliminary study suggests that a novel therapy may help improve cognitive functioning in patients with Alzheimer disease by lowering levels of a protein that is involved in the development of the disease, according to an article in the December issue of The Archives of Neurology, one of the JAMA/Archives journals.

According to the article, Alzheimer disease (AD) is thought to be caused by a buildup of "plaque" in the brain which includes the protein beta-amyloid. Scientists believe that blocking the production or accumulation of beta-amyloid in the brain could prevent or slow AD.

Colin L. Masters, M.D., of the University of Melbourne, Parkville, Victoria, Australia, and colleagues developed a study to determine whether clioquinol, a metal-protein attenuating compound (MPAC), might help to reduce beta-amyloid levels and slow the rate of cognitive decline in patients with AD. The compound is thought to work by inhibiting zinc and copper ions from binding to beta-amyloid, thereby helping to dissolve the protein and preventing it from accumulating. Therapies that block metal ions from interacting with other molecules in the body are known as "chelation" therapies.

The researchers conducted a pilot phase 2 clinical trial of their compound in 36 patients with moderately severe AD. Eighteen patients received 125 milligrams of clioquinol twice per day for 12 weeks, then 250 milligrams twice per day for weeks 13 to 24, and 375 milligrams twice per day from weeks 25 to 36. Eighteen patients received similar doses of placebo over 36 weeks.

The patients were given tests to measure cognition at the beginning of the study and again at weeks 4, 12, 24, and 36. Levels of beta-amyloid in the blood were measured every four weeks.

The researchers found that "plasma beta-amyloid levels declined in the clioquinol group and increased in the placebo group." Patients taking clioquinol also had better scores on tests
'"/>

Contact: Rachel Horton
214-648-3404
JAMA and Archives Journals
15-Dec-2003


Page: 1 2

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 05, 2018 , ... Adam Devlin ... been reappointed to serve on Philadelphia Mayor James F. Kenney’s Commission on People ... who identify with a cognitive or physical disability. Devlin serves as the chair ...
(Date:12/5/2018)... ... , ... A well-known name in the world of gyms and fitness centers ... which has delivered on-demand, virtual fitness programming to employers, gyms and fitness centers, and ... the Apple App Store, the Wellbeats app is fitness that fits for people of ...
(Date:12/5/2018)... ... December 05, 2018 , ... Since PermaLip™ implants ... implants are invisible to the naked eye, ensuring a natural look. “I always double ... there are no signs of implant visibility,” says Dr. Jessica Kulak, double board certified ...
(Date:12/5/2018)... ... 05, 2018 , ... Domenic Palmieri has been named chief ... be responsible for the executive oversight of operations for three core divisions within ... for this position,” Tom Doran, president, HM Insurance Group, said. “And while we ...
(Date:12/5/2018)... ... December 05, 2018 , ... Definitive Healthcare ... market, announced today that it was ranked #184 on Deloitte’s Technology Fast 500 ... highest growth in the fields of technology, media, telecommunications, life science, and energy ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... ... 29, 2018 , ... Access today announced that ... forms and eSignatures functionality accessible via tablets, smartphones, and other portable devices. ... space and it’s about time hospital solutions caught up,” said Access founder and ...
(Date:11/28/2018)... ... ... nJoy Vision is now able to provide a new solution for patients ... FDA approval of STAAR Surgical’s Visian Toric ICL. The first procedure in the state ... 29th by Edward Jones, MD and at nJoy Vision Tulsa on December 7th by ...
(Date:11/28/2018)... ... November 28, 2018 , ... MedHab, the creator of wearable technologies and ... Comfort Keepers to offer MyNotifi’s automated fall detection devices to the entire network ... dramatically. In fact, according to the National Council on Aging, over half of America’s ...
Breaking Medicine Technology:
Cached News: